SI
DXCM icon

Sofinnova Investments’s DexCom DXCM Stock Holding History

Sofinnova Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-393,576
Closed -$24.7M – 69
2026
Q1 		$24.7M Buy
393,576
+15,357
+4% +$1.07M 0.94% 34
2025
Q4 		$25.1M Sell
378,219
-401,397
-51% -$26M 1.08% 34
2025
Q3 		$52.5M Buy
779,616
+255,922
+49% +$20.3M 2.87% 9
2025
Q2 		$45.7M Buy
523,694
+127,719
+32% +$10M 2.8% 10
2025
Q1 		$27M Buy
395,975
+105,765
+36% +$8.63M 1.77% 17
2024
Q4 		$22.6M Buy
+290,210
New +$21.5M 1.64% 20
2024
Q3 		– Sell
-61,494
Closed -$6.97M – 71
2024
Q2 		$6.97M Buy
+61,494
New +$7.77M 0.36% 50
2024
Q1 		– Sell
-20,000
Closed -$2.48M – 76
2023
Q4 		$2.48M Sell
20,000
-530,197
-96% -$54.2M 0.14% 44
2023
Q3 		$51.3M Buy
550,197
+179,477
+48% +$20.2M 3.24% 7
2023
Q2 		$47.6M Buy
370,720
+113,493
+44% +$13.7M 3.12% 11
2023
Q1 		$29.9M Buy
257,227
+116,549
+83% +$13M 1.91% 13
2022
Q4 		$15.9M Sell
140,678
-65,270
-32% -$7.17M 0.95% 26
2022
Q3 		$16.6M Buy
205,948
+16,856
+9% +$1.43M 0.97% 22
2022
Q2 		$14.1M Buy
189,092
+28,032
+17% +$2.56M 1.17% 23
2022
Q1 		$20.6M Buy
161,060
+31,444
+24% +$3.44M 1.56% 14
2021
Q4 		$17.4M Sell
129,616
-19,448
-13% -$2.79M 1.02% 26
2021
Q3 		$20.4M Buy
149,064
+14,212
+11% +$1.79M 1.21% 17
2021
Q2 		$14.4M Buy
134,852
+26,852
+25% +$2.58M 0.83% 32
2021
Q1 		$9.7M Buy
+108,000
New +$10.1M 0.58% 34

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sofinnova Investments's DXCM Position: Q2 2026 in Review

Sofinnova Investments sold out of DexCom (DXCM) in Q2 2026, closing a stake of 393,576 shares — an estimated $24.7M sold.

Sofinnova Investments first reported a position in DXCM in Q1 2021 and held it in 19 quarters. The position peaked at $52.5M in Q3 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Sofinnova Investments reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Sofinnova Investments sold 393,576 DexCom shares in Q2 2026, an estimated $24.7M.
  • Sofinnova Investments first reported a position in DexCom in Q1 2021 and held it in 19 quarters.
  • Sofinnova Investments's DexCom position peaked at $52.5M in Q3 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.